26
Participants
Start Date
March 20, 2025
Primary Completion Date
November 30, 2027
Study Completion Date
November 30, 2027
Low-Dose Radiation(LDRT) + Stereotactic body radiotherapy (SBRT)
"Radiation: Stereotactic Body Radiation Therapy (SBRT)~* Stereotactic Body Radiation Therapy (SBRT) will be performed first at a total dose of 20-50 Gy, delivered in 3-5 fractions of 6-10 Gy each. And the target area was specifically selected based on the location and size of the patient's tumor.~Radiation: low-dose radiotherapy (LDRT)~* Whole-abdominal low-dose radiotherapy will be initiated within 10 days of the end of SBRT with a total dose of 7-15 Gy at 0.5-2.0 Gy twice daily. And the target area included all suspicious tumor tissues and potential metastatic foci in the abdominal cavity."
Cadonilimab
· Cadonilimab: 6 mg/kg IV, D1, Q2W, until disease progression, death, toxicity intolerance or withdrawal of informed consent
The First Affiliated Hospital of Chongqing Medical University, Chongqing
Collaborators (1)
Akeso Pharmaceuticals, Inc.
OTHER
Zhang Tao
OTHER